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Abstract
Background: Antenatal care (ANC) reduces maternal and perinatal morbidity and mortality directly through the
detection and treatment of pregnancy-related illnesses, and indirectly through the detection of women at increased
risk of delivery complications. The potential benefits of quality antenatal care services are most significant in low-resource
countries where morbidity and mortality levels among women of reproductive age and neonates are higher.
WHO developed an ANC model that recommended the delivery of services scientifically proven to improve maternal,
perinatal and neonatal outcomes. The aim of this study is to determine the effect of an intervention designed
to increase the use of the package of evidence-based services included in the WHO ANC model in Mozambique.
The primary hypothesis is that the intervention will increase the use of evidence-based practices during ANC visits
in comparison to the standard dissemination channels currently used in the country.
Methods: This is a demonstration project to be developed through a facility-based cluster randomized controlled
trial with a stepped wedge design. The intervention was tailored, based on formative research findings, to be readily
applicable to local prenatal care services and acceptable to local pregnant women and health providers. The intervention
includes four components: the provision of kits with all necessary medicines and laboratory supplies for ANC (medical
and non-medical equipment), a storage system, a tracking system, and training sessions for health care providers. Ten
clinics were selected and will start receiving the intervention in a random order. Outcomes will be computed at each
time point when a new clinic starts the intervention. The primary outcomes are the delivery of selected health
care practices to women attending the first ANC visit, and secondary outcomes are the delivery of selected health
care practices to women attending second and higher ANC visits as well as the attitude of midwives in relation
to adopting the practices. This demonstration project is pragmatic in orientation and will be conducted under
routine conditions.
(Continued on next page)
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Discussion: There is an urgent need for effective and sustainable scaling-up approaches of health interventions in
low-resource countries. This can only be accomplished by the engagement of the country’s health stakeholders at
all levels. This project aims to achieve improvement in the quality of antenatal care in Mozambique through the
implementation of a multifaceted intervention on three levels: policy, organizational and health care delivery levels.
The implementation of the trial will probably require a change in accountability and behaviour of health care providers
and we expect this change in ‘habits’ will contribute to obtaining reliable health indicators, not only related to research
issues, but also to health care outcomes derived from the new health care model. At policy level, the results of this
study may suggest a need for revision of the supply chain management system. Given that supply chain management
is a major challenge for many low-resource countries, we envisage that important lessons on how to improve the
supply chain in Mozambique and other similar settings, will be drawn from this study.
Trial registration: Pan African Clinical Trial Registry database. Identification number: PACTR201306000550192.
Keywords: Antenatal care, Pregnancy

Background
Antenatal care (ANC) and MDGs

In 2000, the United Nations Millennium Declaration and
8 associated Millennium Development Goals (MDGs)
were adopted by 189 countries, signifying the establishment of an unprecedented global partnership to meet
the needs of the world’s poorest populations [1]. MDG 4
calls for a two-third reduction of infant mortality by 2015,
and MDG 5 calls for a 75% reduction of 1990 maternal
mortality levels by 2015 (MDG 5A), and universal access
to reproductive health (MDG 5B) [2,3]. Antenatal care
(ANC) indicators, both at least one visit and four or
more (4+) visits, are MDG 5B tracking indicators – a
recognition in the international community of the central
importance of ANC to women's health.
ANC reduces maternal and perinatal morbidity and
mortality directly through the detection and treatment
of pregnancy-related illnesses, and indirectly through the
detection of women at increased risk of delivery complications [4,5]. Studies showing an association between ANC
utilization and uptake of skilled delivery care also suggest
that ANC can save women and newborn lives through the
promotion of skilled delivery care and counseling on birth
planning and complication readiness [6-8].
ANC visits constitute one of the few times women in
many resource-poor settings seek care for their own
health [9,10] and, therefore, represent an important
opportunity for: 1) reaching women with a number of
interventions that may be vital for their health and the
health of their unborn child (e.g. anaemia, HIV, syphilis
and malaria prevention, detection and treatment), and 2)
informing women about pregnancy, related complications,
and the advantages of skilled delivery care as well as the
importance of birth spacing [11,12].
Current status of ANC in high burden countries

The potential benefits of quality ANC services are most
significant in low-resource countries where morbidity

and mortality levels among women of reproductive age
and neonates are, on average, highest. The Countdown
2013 report which tracks progress in the 75 countries in
the world with the greatest burden of maternal, newborn,
and child mortality where over 95% of all maternal and
child deaths occur, shows a median coverage level across
these countries of 57% for ANC four or more visits (range
in coverage is 15% to 94%) [13].
These figures show that although the delivery and
prioritization of ANC differs across the 75 Countdown
countries, there is an overall need to increase antenatal
care attendance by women. Mozambique, a priority country for Countdown, is not an exception. According to the
Mozambique Demographic and Health Survey (DHS)
2011, 91% of women received at least one ANC visit (up
from 71% in the 1997 DHS), while 51% received 4 or more
visits, with coverage being higher in urban compared with
rural areas (60% vs 47%). The median gestational age at
the first ANC visit was 4–5 months with no differences
between urban or rural areas [14].
WHO ANC model

From 1996–1998, the Department of Reproductive Health
and Research (RHR) at the World Health Organization
(WHO) conducted a multicentre cluster-randomized
controlled trial to evaluate a new ANC model that
recommended the delivery of services scientifically proven
to improve maternal, perinatal and neonatal outcomes
through four antenatal and one postpartum visit (for
women with no evidence of complications). This new
ANC care model was assessed against local models which
required substantially more ANC visits. The WHO model
divides pregnant women into two groups: 1) those with
no evidence of pregnancy-related complications, medical
conditions or major health-related risk factors (75% of the
total population of pregnant women) and eligible for the
basic package of ANC services, and 2) those with specific
health conditions or risk factors that necessitate special
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care (25% of pregnant women). The trial found that the
new WHO model produced maternal and perinatal outcomes comparable to the local models, and was readily
accepted by women and health care providers [15].
A subsequent WHO systematic review of randomized
controlled trials of routine ANC similarly concluded that
a model with a reduced number of antenatal visits could
be introduced into clinical practice without risk to mother
or baby [16].
Implementation of the WHO ANC model

The WHO ANC model has been implemented in
Thailand, Argentina and Micronesia with positives
results. In anticipation of the potential difficulties of
translating research findings on ANC into clinical
practice, Thailand developed an implementation plan
for the new WHO ANC model before the 1996–1998
trial started. This plan clearly defined the coordinated
actions to be taken at all levels of the health-care system,
from consumers, health professionals, responsible country
authorities to international organizations, for successful
introduction of the model [17].
In Argentina, policy-makers at national and local levels
were involved in rolling out the WHO ANC model after its
implementation was approved in early 2003 (unpublished
information, personal communication, Centro Rosarino
de Estudios Perinatales, CREP). The WHO ANC model
has been fully institutionalized throughout Yap State in the
Federated States of Micronesia (unpublished information,
personal communication, Centro Rosarino de Estudios
Perinatales, CREP). In all cases, implementing the new
model required coordinated efforts among all actors
involved in the ANC process, training sessions to the
personnel (in person or on line) and dissemination
strategies to make the ANC model familiar to healthcare workers.
The above are good examples of how research findings
on ANC can be effectively translated into clinical practice.
However, the implementation processes adopted in the
three countries were not carried out within the framework
of a rigorous research protocol. Consequently, there is
no strong evidence showing that the adopted strategies
are significantly better than other approaches to implementing the WHO ANC model. It is also not clear
whether the strategies can be replicated in other similar
contexts, as they were designed in relation to specific
local conditions in the three countries. This proposed
study will address this knowledge gap by generating
new evidence based on the findings of a methodologically
sound intervention protocol.
Mozambique ANC model

In December 2008, the Ministry of Health of Mozambique
launched the Integrated Plan for the achievement of MDGs
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4 and 5. The plan included an integrated package of interventions for pregnant women, newborns and children
below 5 years of age. The interventions for pregnant
women are based on the WHO ANC model in a minimum
of four antenatal visits and one post-partum visit including
basic interventions for non-complicated pregnancies and
additional interventions for complicated pregnancies.
The initial experience with the introduction of the
ANC model in Mozambique has indicated that bottlenecks and health system deficiencies are limiting the full
implementation of the model at health facility level. A
meeting of experts convened in Maputo in 2009 by the
Ministry of Health, the WHO, and the Flanders International Cooperation Agency (FICA) highlighted lack
of motivation and knowledge among care providers as
potential determinants of this situation.
This proposed study builds extensively on the recommendations of this meeting and is considered by the
Ministry of Health as an important opportunity to generate
knowledge for the development of strategies to improve the
quality and integration of ANC services at national level.
All references to the “ANC model” in the remainder of this
protocol concern the Mozambique ANC model.
Evidence-based strategies to disseminate and implement
maternal and child health services at primary care level

A major challenge in developing countries is to bridge
the ‘know-do gap’ and make scientifically proven interventions widely available to underserved populations.
There is an urgent need for new approaches that will
enable scaling-up of effective and beneficial interventions
in developing country contexts. Evidence shows that
quality improvement interventions (broadly defined as
strategies to ensure delivery of effective services efficiently
and equitably) can be used to disseminate evidence-based
practices among clinicians in high income countries
[18-20]. Whether this can be achieved in resource-poor
settings is uncertain, as there is little research done in
low or middle-income countries (LMIC).
A systematic review of systematic reviews published in
2008 analyzed strategies for improving the quality of care
of maternal and child health (MCH) services in developing countries [21]. The 23 systematic reviews (including 9
Cochrane reviews) evaluated the effects of continuing
education and quality improvement strategies, financial
and reimbursement strategies (e.g. provider incentives),
and organization of care strategies on the delivery of
MCH services. The main findings of the overview can
be summarized as follows: 1) Interactive workshops,
reminders and multifaceted interventions (that combine
two or more strategies) can improve health care practice,
and generally have moderate effects; 2) Educational outreach visits consistently improve targeted health seeking
behaviours but have variable effects on other behaviours
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contributing to poor health outcomes; 3) Audit, feedback
and the use of opinion leader interventions have small to
moderate effects on provider practices. There was not
enough information at that time to draw implications for
clinical practice or public health policy from other quality
improvement strategies including financial incentives, and
organizational or regulatory interventions.
One key study testing a strategy for implementing
evidence-based childbirth and other maternal care practices in developing countries was conducted in Latin
America during 2004–2007. This was a multicenter cluster
randomized trial in 19 public maternity hospitals in
Argentina and Uruguay with the specific aim to increase the use of two evidence-based practices during
childbirth: the use of oxytocin during the third stage of
labor and selective episiotomy. The trial evaluated the
effect of a behavioural intervention on the implementation
of evidence-based clinical guidelines on the prevention of
post-partum haemorrhage and the use of episiotomy. A
multifaceted approach consisting of training to perform
evidence-based practices, academic detailing, reminders
and feedback was used to disseminate, implement, and
maintain the guidelines in the hospitals. This multifaceted
approach showed changes and sustainability in the practices under study [22].
Study aims and hypotheses

The main specific aim of this study is to determine the
effect of an intervention designed to increase the use of
evidence-based practices included in the ANC package
by midwives (and other health professionals) in prenatal
clinics in Mozambique. Specifically, we will assess the
effect of the intervention on practices related to the detection, treatment and prevention of major health-related
conditions (e.g., anaemia, and infectious diseases such as
HIV/AIDS, malaria, and congenital syphilis).
Our primary hypothesis is that the intervention will
increase the use of such practices in comparison to the
standard dissemination channels currently used in the
country. A secondary hypothesis is that the intervention
will improve the attitudes and readiness of midwives (and
other health professionals) to provide all recommended
practices during ANC visits to their women clients.
We set out to assess if a multifaceted intervention with
several interacting components to increase the use of
evidence-based practices in an ANC package would be
effective in improving the quality of care of maternal
and child health services in Mozambique [19].

Methods
This will be a facility-based cluster randomized controlled
trial with a stepped wedge design. Figure 1 summarizes
the study design. The intervention will be rolled out
sequentially to ten ANC clinics in three regions of
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Mozambique starting a new facility every two months.
After two months of baseline data collection in all facilities (months 1 and 2), facility 1 will start at month 3,
facility 2 will start at month 5, etc. The order in which
the clinics receive the intervention will be determined
at random and, by the end of study, all clinics will have
received the intervention. Outcomes will be computed at
each time point when a new clinic starts the intervention.
Complex interventions such as that planned for this
trial are challenging to evaluate because of the organizational and logistical difficulties involved in designing and
delivering the intervention in a standardized way across
participating facilities. Interventions aimed at improving
quality of care and access to services are also often ethically
and politically challenging to withhold from a proportion
of participant clusters (or to withdraw the intervention
as would occur in a cross-over design) [23]. In addition, because of logistical and financial constraints, the researchers
determined that the planned intervention could only be
implemented in stages. In such circumstances, determining
the order in which clusters receive the intervention at
random is more acceptable to implementers and policy
makers. For all of these reasons, the stepped wedge design
was considered advantageous to use for this trial [24].
Study population
Participating clusters and women

This study will be conducted in 10 ANC clinics in the
three regions of Mozambique. The Ministry of Health
pre-selected the 10 clinics according to their programmatic activities and priorities. The pre-selected clinics are
shown in Table 1 and Figure 2. They account for a significant proportion of the annual ANC visits in the country.
Clinics were eligible if (1) they were not already implementing the proposed ANC model; (2) they served at
least 200 new pregnant women per year; (3) they had
midwives or nurses-midwives among their personnel;
and (4) they were willing to participate. All women
attending ANC visits at the participating clinics will be
eligible to receive the ANC package.
Sample size calculation

The sample size was estimated very conservatively, assuming a baseline frequency of selected health practices of 30%,
and an increase to 60% in the prenatal clinics assigned to
the intervention group. For a 0.05 alpha level, 80% power
and an intra-cluster correlation coefficient of 0.05, six clusters will be needed. To protect against pre-randomization
exclusions and drop outs, 10 clinics will be included.
The intervention

The intervention was designed and tailored based on the
results of an analysis of previously collected data by the
Mozambique Ministry of Health from the National Needs
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Figure 1 Flow chart of the trial.

Assessment on Maternal and Neonatal Health [25] and the
results of formative research using qualitative methods.
National needs assessment on maternal and neonatal health

The Ministry of Health of Mozambique conducted a
national survey at facility level to assess the quality of
care of maternal and child health services [25]. The survey

was conducted in facilities selected randomly and consisted of several modules focusing on human resources
available, characteristics of prenatal care, women’s satisfaction, maternal and neonatal health indicators, and
information on barriers and factors that contribute to
the delay in seeking appropriate medical help for obstetric
care.

Table 1 Pre-selected ANC clinics
Region

Health Center (HC)

Women attending 1st ANC in 2011

South
Maputo City

HC 1ro de Maio

3,165

Maputo Province

HC da Matola II

3,276

Gaza

HC annexed to the rural hospital of Chowke

3,480

Gaza

HC of Chibuto

9,756

Sofala

HC annexed to the district hospital of Dondo

2,728

Tete

HC annexed to the rural hospital of Songo

1281

Tete City

HC N° 2

2778

Nampula City

HC 25 de Setembro

5,960

Nampula District

HC of Anchilo

1,894

Cabo Delgado

HC annexed to the rural hospital of Montepuez

4,182

Central

North
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Figure 2 Map of Mozambique showing the regions and pre-selected ANC clinics. Credits: Siv Steffen Nygaard, WHO Mozambique.

In the context of this trial, the data from the survey were
analyzed for the facilities that had been pre-selected for
this demonstration project by the Ministry of Health to
provide information on the current rates of use of the
evidence-based practices included in the ANC package,
which practices were underutilized or not utilized and
what were the barriers and facilitating factors to the
correct implementation of the selected practices. Five of
the pre-selected facilities were included in the survey and
all of them have antenatal care services.

Formative research

Understanding the barriers that hinder health practitioners’ ability or willingness to implement evidence based
practices is critical for the implementation of any strategy
aimed at improving provider uptake of these practices
[26]. Thus, a qualitative study was carried out in 2011
during the preparatory phase of the trial to ensure that
the implementation strategy would be effective, culturally
appropriate, and accepted by women and ANC providers
[27,28].
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The specific aims were:
1. To obtain and analyze information to define the
components of the intervention strategy by: a)
Identifying system and individual factors which
influence the successful adoption of scientific
recommendations in obstetric practice, and
mechanisms for effectively introducing evidencebased practices within routine prenatal care; and b)
Identifying the barriers and facilitating factors for the
implementation of the evidence-based specific practices
in the WHO ANC package at prenatal clinics.
2. To evaluate the appropriateness of the proposed
intervention by: a) Assessing prenatal care providers’
and clinic authorities’ perspectives regarding the
components of the intervention; b) Assessing
women’s perspectives on routine ANC.
The methods used included focus groups with prenatal
care providers and women, and in-depth interviews with
clinics authorities as needed. The main barriers identified
regarding the service and behavioral components were
the lack of infrastructure, instruments and materials, and
stock of products needed for delivery of recommended
ANC services, inappropriate training of the personnel
involved in all stages of ANC, and the lack of a registration system for records. Regarding the procurement
and supply chain management component, barriers were
related to qualified stock records, reliable data and weak
implementation of a supply system including transport.
Description of the intervention

The multifaceted intervention includes the following four
components:
COMPONENT 1: ANC kits containing the necessary
medicines, laboratory supplies, materials and equipment.
Four different kits were designed. Each clinic will be
provided with the ANC kits which include the products
required for the ANC consultations (first and follow-up
visits) according to the current protocols and norms
legislated by the Ministry of Health. The number of kits
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has been calculated and designed so that each clinic will
have provisions for one month. Table 2 shows the 4 types
of kits that will be produced and used at the clinics.
COMPONENT 2: Availability of a cupboard
There will be a cupboard in the room where the ANC
visit will take place, which will serve as a storage place
for the kits. This will allow easy and quick access of the
nurses to all necessary materials while the woman is in the
room, enabling the nurses to provide care comprehensively
and improving the delivery and quality of the necessary
ANC interventions in a most efficient manner.
COMPONENT 3: Tracking sheet
The intervention includes the use of a tracking sheet
(so-called “ficha”) for the research assistants to monitor
the stock levels of the various products in the kits. The
tracking sheet will enable the study to monitor kit use
and avoid stock-outs.
COMPONENT 4: Training session
At the start of the intervention in each site, a refresher
course on the essential and complementary
interventions for ANC will be given to all the MCH
nurses working in the health facilities of the study.
MCH nurses are responsible for delivering ANC in
Mozambique. They will also be re-trained in using the
materials and products, such as proteinuria test, blood
pressure measurement, etc. The training will also
include the use of the kits, use of the tracking sheet
and procedures to ensure continuous supply of the
medicines and materials needed. The training session
will be a 3-day course and it will be led by the Ministry
of Health in collaboration with the partners involved in
this project.
In accordance with the stepped wedge design, the intervention will be rolled out sequentially to the ten ANC clinics
in an order that will be decided randomly. Before the intervention is rolled out in a particular clinic, this clinic will
receive no intervention but will be asked to continue with
standard in-service training activities.
This demonstration project is pragmatic in orientation
and will be conducted under routine conditions. Under such
conditions, non-compliance is embedded in the evaluation.

Table 2 Types of kits and content to be produced and used at the clinics
Kit

Type of visit

Overall content

Specific content

A

First visit

All products needed for
the 1st consultation

Test strips for urine proteins, hemoglobin, Rapid Diagnostic Test for HIV and
syphilis, benzathine penicillin, mebendazole, sufadoxine-pyrimethamanine,
ferrous sulphate/folic acid tablets, cotrimoxazole, antiretroviral (ARV) as
well as medical devices to administer these medications and perform
clinical examinations.

B

Follow up visit

All products needed for the
follow up consultations

The same components of kit A except for syphilis rapid test, benzathine
penicillin and mebendazole.

C

First and follow up visits

Urine collecting containers

D

First and follow up visit

Long lasting impregnated bed nets
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Reasonable measures will be implemented to improve
compliance [29].
Outcome measures
Primary outcomes

The primary outcome will be the delivery of selected health
care practices to women attending the first antenatal care
visit. Three practices will be chosen from the list of priority
practices below, after evaluating their current use during
the baseline period and before implementation of the
intervention. Practices that are not selected as primary
outcomes will be incorporated as secondary outcomes.











Frequency of women receiving screening for syphilis
Frequency of women receiving screening for HIV
Frequency of women receiving screening for anaemia
Frequency of women receiving screening for
hypertension
Frequency of women receiving tetanus toxoid
Frequency of women receiving intermittent
preventive malaria treatment
Frequency of women receiving iron supplementation
Frequency of women receiving anti-parasitic treatment
(de-worming)
Frequency of syphilis sero-positive women receiving
the administration of syphilis treatment
Frequency of HIV sero-positive women receiving
administration of antiretroviral treatment.

Secondary outcomes

Selected practices in each ANC visit after the first ANC
visit:












Frequency of women receiving screening for syphilis
Frequency of women receiving screening for HIV
Frequency of women receiving screening for anaemia
Frequency of women receiving screening for
hypertension
Frequency of women receiving tetanus toxoid
Frequency of women receiving intermittent
preventive malaria treatment
Frequency of women receiving iron supplementation
Frequency of women receiving anti-parasitic
treatment (de-worming)
Frequency of syphilis sero-positive women receiving
the administration of syphilis treatment
Frequency of HIV sero-positive women receiving
administration of antiretroviral treatment
Frequency of midwives’ positives attitudes and
readiness to provide the selected practices.

Composite outcome

A score will be computed. One point will be added to the
score for each selected practice that was implemented. A
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woman receiving all selected practices will get the highest
possible score, while a woman who receives none of the
practices will get a score equal to zero. Two sets of scores
will be computed, one for the first ANC visit, and one for
subsequent visits.

Process measures

Process data will be collected during the intervention
period at prenatal clinics. The objectives of this process
evaluation are: 1) to detect implementation problems that
could be explanatory in case the intervention was not
effective; and 2) to facilitate the replication and scale-up of
the intervention if it is proven effective.

Data collection and management
Source of data for primary outcomes

The Ministry of Health of Mozambique has designed a
data collection instrument to be used for the registration
of ANC data at national level in order to obtain uniform
and comprehensive data from all health units. This preprinted Book of Registration of Antenatal Care Data (Livro
de Registro da Consulta Pre-natal) has been distributed
to all health facilities, and all ANC providers are required
to complete it for each ANC visit. The unit of registration
is the antenatal visit (not the woman visited). However, in
order to be able to compute individual-based indicators, a
system will be in place by which each woman will be
assigned a code/number that will be reflected in the
logbook. The visits and the women will be linked by
this code maintaining, however, the anonymity of the
woman. This will be achieved by means of a card (the
size of a visiting card) that would be given to the mother
on the first ANC visit and should be carried with her
ANC card to every ANC visit. This card will be assigned a
code/number and will be composed of 12–15 small
stickers with the same code/number. When the woman
comes to the ANC visit, the nurse will take one of the
stickers and place it in the logbook in the row corresponding to that visit.
The variables in the registration book are the following:
date of prenatal visit, name, age, address, number of ANC
visits for this pregnancy, gestational age, blood pressure,
malnutrition, anaemia, proteinuria, examination of the
breast (presence of nodules), screening and treatment
of syphilis (for the woman and her partner) and other
sexually transmitted infections, tetanus immunization
status, screening, prevention and treatment of maternalto-child transmission of HIV, prevention of malaria with
intermittent preventive treatment, iron administration,
anti-parasitic treatment, distribution of bed nets, partner
coming to the visit, reference to another health facility
and name of health provider.
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Quality data monitoring and quality control

A comprehensive quality assurance and quality control will
be put in place to ensure that the best possible data will be
filled in the registration book and entered into the database.
Guidelines for collecting data and filling in the registration
book will be produced. To ensure that the data will be collected in a standardized way in all the participating clinics,
a pilot testing of data collection and data management will
be conducted prior to the start of the baseline data collection. Data quality monitoring reports will be produced
regularly for each clinic. Site monitoring visits to the
participating clinics will be conducted routinely and source
data verification (SDV) will be performed to ensure that the
data collected are complete, accurate and reliable.
Additionally, data quality control mechanisms will be
implemented in order to ensure reliability of the data obtained through routine data collection. These mechanisms
will include surveys on a random sample of pregnant
women attending ANC clinics at exit from the facilities.
Selected women will be approached as they are leaving
the facility after the ANC visit to conduct the exit survey
and they will be asked to participate by signing a consent
form. These women will be invited to answer a set of
questions related to the practices and other variables
collected in the registration book (primary source of
data) in order to evaluate if the information registered
is identical to the data collected in the exit survey. If
differences are observed, providers will be interviewed in
order to resolve them. Three surveys will be conducted
for this purpose at three points in time; each time point
with 1000 surveys (100 questionnaires per clinic). The first
survey will be carried out just before starting intervention;
the second at 12 months and the last at 20 months,
approximately.
Source of data for secondary outcomes: willingness of health
professionals who provide antenatal care to adopt the
practices recommended in the WHO model

The data will be collected at two data points: one within
the first four months of the study period and the second
within the last two months of the study period. A selfadministered questionnaire on paper forms will be used.
These forms will be sent to the data management center.
This survey is designed to assess the willingness of
health professionals who provide antenatal care to adopt
the practices recommended. The questions are about
their perceptions of these practices and viewpoints on
any barriers or facilitating factors that may affect the
adoption of these practices and national guidelines.
The survey will be administered in all participating health
care centers. The information obtained from this questionnaire the first time will be used as baseline data and will be
compared to results from the same questionnaire administered after the intervention. The project data collector will

Page 9 of 11

be responsible for the administration of the surveys, and informed consent will be obtained from all participants. The
questionnaire will be provided to health care professionals
in an unmarked opaque envelope.
Data management

A web-based data management (DM) system will be used
to enter the data and to monitor the data quality. The
system will be developed by the Biostatistics and Data
Management (SIS) team at UNDP/UNFPA/UNICEF/
WHO/World Bank Special Programme of Research,
Development and Research Training in Human Reproduction (HRP) at WHO in Geneva using the OpenClinica
Application available at: https://www.openclinica.com,
version 3.1.3 [30]. The system will include programmed
edit checks to validate completeness, accuracy and consistency of the data entered. The OpenClinica system is an
open-source software, highly secure and reliable web-based
solution, fully compliant with Good Clinical Practice (GCP)
and regulatory guidelines as well as the HRP/WHO Standard Operating Procedures (SOPs) for managing clinical
trials. These procedures have been used in previous
international multicentre trials sponsored or coordinated
by WHO in the past five years and proven to be efficient.
The online data entry system minimizes the delays in data
queries, completion of forms and problem resolution; it
makes the dataset quickly available and permits continuous assessment of data quality.
Data management will be performed locally in Maputo
by the Consultorio de Estatistica e Serviço de SoluçoesLDA (CESS) and by the WHO/SIS team. The team in
Maputo will be trained in data-entry and data management
using the OpenClinica system.
The nurses of all participating clinics will be trained in
data collection and filling the registration book following
an instructions booklet. Research assistants from clinics
will be trained to take digital photos of the registration
book and send them to the data management center.
Photos will be sent from each facility by email on weekly
basis. CESS will be responsible for verifying the data from
the photos, uploading them to dropbox and entering the
data into the OpenClinica system. Double data entry
will be performed to minimize errors. Queries on data
(missing values, outliers, inconsistencies and other errors)
will be generated automatically in the system. Data quality
will be monitored online by the WHO/SIS Team at WHO.
Standard ASCII or SPSS or SAS datasets will be generated from the final study database ready for analysis.
Statistical analysis

Descriptive statistics will be reported by computing frequencies and percentages for categorical variables and means,
standard deviations, and minimum and maximum values
for continuous variables. Distribution of the variables will be
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examined to detect the outliers as a part of quality control
and descriptive analysis of the data. Descriptive statistics will
be tabulated for individual clusters and aggregated across
clusters.
There have been many suggested approaches to the analysis of stepped wedge designs, ranging from repeated application of purely between-unit analysis for each step, to the
application of purely within-unit analysis, usually performed
by some form of interrupted time series analysis. We will
follow the general approach set out by Hussey et al. [31].
The primary objective of the study is to estimate the effectiveness of the intervention. The generalised linear mixed
model (GLMM) will be used in this analysis to provide an
estimate of the intervention effect, using both between and
within ANC clinics effects. STATA and SAS statistical packages will be used for the analysis.
Duration of the project

The proposed study will require 61 months including the
formative research. The deployment of the intervention
will required 22 months (See Figure 1).
Limitations

There are some limitations regarding the stepped weighed
design, such as a greater complexity in the implementation
of the intervention, in some case a longer trial duration.
However the strengths outweigh the limitations.
Ethical aspects

This protocol has been approved by the Research Project
Review Panel of the UNDP/UNFPA/UNICEF/WHO/World
Bank Special Programme of Research, Development and
Research Training in Human Reproduction at the Department of Reproductive Health and Research of WHO, and
the WHO Research Ethics Review Committee, Geneva,
Switzerland. The Comité Nacional de Bioéticapara a
Saúde of the Ministry of Health in Mozambique also
approved the study.
A waiver of consent forms for participating women was
obtained since this study is considered of minimal risk
(risks of daily life, and includes the risks associated with
routine physical examinations and review of medical
records) and it is developed in the context of regular
prenatal care and using as research records those used
in health care process (no data collection tools have
been developed to gather data regarding women’s health
for the study). Recommendations provided for The
Ottawa Statement on the Ethical Design and Conduct
of Cluster Randomized Trials were taken into account
in the design of this trial [32].

Discussion
There is an urgent need for approaches to achieve effective and sustainable scaling-up of beneficial interventions
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in developing counties and particularly in low-resource
settings. This can only be accomplished by the engagement of the country’s health stakeholders at all levels. This
project aims to achieve improvement in the quality of
antenatal care in Mozambique through the implementation of a multifaceted intervention on three levels: policy
level, organizational level and health care delivery level.
Coordination of such a complex intervention is expected
to be challenging. Foreseen difficulties include: organizational and logistical difficulties in delivering the intervention, adjusting to government, political and policy changes,
and maintaining timelines, as much as possible. However,
the methodology proposed integrates all required components to achieve the objectives and we have the cooperation
of a multidisciplinary team of internationally recognized
researchers and implementers for this project.
The idea of using the registration book as the instrument
for data collection is critically important. It represents
the best source of data for the primary outcomes of this
research study because it is endorsed at the national level,
and is mandatory for all health providers to complete.
Importantly, by using this instrument, data collection for
the demonstration project will not additionally burden the
health professionals. The Ministry of Health has given
the authorization to use this instrument to analyze ANC
practices in the context of this study.
The proposal to gather effective and efficient data on the
availability of supplies and to use this information to avoid
shortages or stock outs, represents an innovative approach
emerging from the formative research. This activity will
require not only data collection, but also the use of the data
collected to avoid stock outs. This will help ensure that
supply chain management and the allocation of resources
is based on relevant data and adjusted to local needs.
Implementing the proposed activities will also require
a change in accountability and behaviour of health care
workers (mainly health care providers) since participating
in this kind of research requires an accurate and standardized registration of all activities involved in the health care
process. We expect this change in “habits” will contribute
to obtaining reliable health indicators, not only related to
research issues, but also to health care outcomes derived
from the new health care model.
At policy level, the results of this study may suggest a
need for revision of the existing supply chain management system. Given that supply chain management is a
major challenge for many low-resource countries like
Mozambique, we envisage that important lessons with
application to Mozambique and to other similar settings
on how to improve the supply chain will be drawn from
this study.
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